Owner Chromaceutical Advanced Technologies, Inc.

Inventors Beck, Robert A.; Kowalski, John; Mateer, Robert A. Jr.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004251625

PCT Pub. Number WO2005/000210

Priority 60/474,652 30.05.03 US

Filing date 28 May 2004

Wipo publication date 6 January 2005

Acceptance publication date 27 October 2011

C07H 3/00 (2006.01) Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms

A61K 31/191 (2006.01)

A61K 31/295 (2006.01)

A61K 31/7004 (2006.01) - Monosaccharides having only carbon, hydrogen and oxygen atoms

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61K 31/7012 (2006.01) - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid

A61K 31/7016 (2006.01) - Disaccharides, e.g. lactose, lactulose

A61K 31/7024 (2006.01) - Esters of saccharides

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

A61K 33/26 (2006.01) Medicinal preparations containing inorganic active ingredients - Iron

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C08B 37/02 (2006.01) Preparation of polysaccharides not provided for in